ELAN
Price
$18.45
Change
-$0.19 (-1.02%)
Updated
Sep 17, 04:58 PM (EDT)
Capitalization
9.26B
55 days until earnings call
VTRS
Price
$9.65
Change
+$0.09 (+0.94%)
Updated
Sep 17, 04:08 PM (EDT)
Capitalization
11.19B
54 days until earnings call
Interact to see
Advertisement

ELAN vs VTRS

Header iconELAN vs VTRS Comparison
Open Charts ELAN vs VTRSBanner chart's image
Elanco Animal Health
Price$18.45
Change-$0.19 (-1.02%)
Volume$38.91K
Capitalization9.26B
Viatris
Price$9.65
Change+$0.09 (+0.94%)
Volume$13.19K
Capitalization11.19B
ELAN vs VTRS Comparison Chart in %
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. VTRS commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and VTRS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (ELAN: $18.63 vs. VTRS: $9.56)
Brand notoriety: ELAN: Notable vs. VTRS: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 62% vs. VTRS: 110%
Market capitalization -- ELAN: $9.26B vs. VTRS: $11.19B
ELAN [@Pharmaceuticals: Generic] is valued at $9.26B. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $11.19B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.82B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 3 TA indicator(s) are bullish while VTRS’s TA Score has 6 bullish TA indicator(s).

  • ELAN’s TA Score: 3 bullish, 5 bearish.
  • VTRS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а -0.69% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was -8.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +28.13%. For the same industry, the average monthly price growth was +27.16%, and the average quarterly price growth was +62.24%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 11, 2025.

VTRS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+28.13% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($11.2B) has a higher market cap than ELAN($9.26B). VTRS has higher P/E ratio than ELAN: VTRS (236.20) vs ELAN (21.17). ELAN YTD gains are higher at: 53.840 vs. VTRS (-20.237). ELAN has higher annual earnings (EBITDA): 1.45B vs. VTRS (-493.3M). VTRS has more cash in the bank: 809M vs. ELAN (539M). ELAN has less debt than VTRS: ELAN (4.21B) vs VTRS (14.8B). VTRS has higher revenues than ELAN: VTRS (14.1B) vs ELAN (4.48B).
ELANVTRSELAN / VTRS
Capitalization9.26B11.2B83%
EBITDA1.45B-493.3M-294%
Gain YTD53.840-20.237-266%
P/E Ratio21.17236.209%
Revenue4.48B14.1B32%
Total Cash539M809M67%
Total Debt4.21B14.8B28%
FUNDAMENTALS RATINGS
ELAN vs VTRS: Fundamental Ratings
ELAN
VTRS
OUTLOOK RATING
1..100
5354
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7996
PRICE GROWTH RATING
1..100
4060
P/E GROWTH RATING
1..100
901
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (12) in the null industry is significantly better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew significantly faster than ELAN’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (79) in the Agricultural Commodities Or Milling industry is in the same range as VTRS (96) in the null industry. This means that ELAN’s stock grew similarly to VTRS’s over the last 12 months.

ELAN's Price Growth Rating (40) in the Agricultural Commodities Or Milling industry is in the same range as VTRS (60) in the null industry. This means that ELAN’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for ELAN (90) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew significantly faster than ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANVTRS
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 10 days ago
62%
Bullish Trend 16 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
73%
Bearish Trend 2 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMQX6.050.03
+0.50%
Invesco SteelPath MLP Income R5
SPIIX107.28N/A
N/A
SEI S&P 500 Index I (SIMT)
STRGX62.57N/A
N/A
Sterling Capital MdCp Relatv Val Instl
MOSZX9.93N/A
N/A
MassMutual Overseas I
RLBEX38.56-0.01
-0.03%
American Funds American Balanced R4